Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -229,864 | -152,893 | -81,499 | -181,223 | -111,894 |
| Depreciation Amortization | 13,843 | 9,921 | 5,109 | 15,596 | 10,988 |
| Income taxes - deferred | N/A | N/A | N/A | -93,649 | -94,824 |
| Accounts receivable | 1,485 | -2,817 | -3,611 | -7,166 | -6,871 |
| Accounts payable and accrued liabilities | 1,511 | 1,331 | 6,373 | 6,363 | 196 |
| Other Working Capital | -48,290 | -33,707 | -24,765 | 20,327 | 9,841 |
| Other Operating Activity | 58,670 | 38,573 | 19,364 | 128,572 | 113,092 |
| Operating Cash Flow | $-202,645 | $-139,592 | $-79,029 | $-111,180 | $-79,472 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 47,526 | -10,571 | 45,691 | -352,807 | -421,402 |
| PPE Investments | -11,846 | -7,657 | -3,638 | -5,931 | -3,089 |
| Net Acquisitions | N/A | N/A | N/A | -319,793 | -319,793 |
| Investing Cash Flow | $35,680 | $-18,228 | $42,053 | $-678,531 | $-744,284 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 895,536 | 895,536 |
| Debt Repayment | -1,180 | -770 | -377 | -361 | 0 |
| Common Stock Issued | 9,983 | 6,440 | 5,592 | 326,651 | 324,967 |
| Other Financing Activity | 0 | 0 | 0 | -52,245 | -52,246 |
| Financing Cash Flow | $8,803 | $5,670 | $5,215 | $1,169,581 | $1,168,257 |
| Beginning Cash Position | 465,817 | 465,817 | 465,817 | 85,947 | 85,947 |
| End Cash Position | 307,655 | 313,667 | 434,056 | 465,817 | 430,448 |
| Net Cash Flow | $-158,162 | $-152,150 | $-31,761 | $379,870 | $344,501 |
| Free Cash Flow | |||||
| Operating Cash Flow | -202,645 | -139,592 | -79,029 | -111,180 | -79,472 |
| Capital Expenditure | -11,846 | -7,657 | -3,638 | -5,931 | -3,089 |
| Free Cash Flow | -214,491 | -147,249 | -82,667 | -117,111 | -82,561 |